LONDON, May 11, 2017 /PRNewswire/ -- Global Pharmerging Market: OverviewThis report on pharmerging market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pharmaceutical products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered within the scope of the study. This section also provides the overall information and data analysis of the global pharmerging market with respect to the leading market segments based on major products, applications and geographies.Download the full report: https://www.reportbuyer.com/product/4895309/The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the global pharmerging market and could influence the market in the near future. Market attractiveness analysis has been provided in all the sections of the report in order to explain the intensity of competition in the market across different products/materials/technologies/end-users/geographies. The competitive scenario among different market players is evaluated through market share analysis in the competition landscape section of the report. The section also includes competition matrix that analyzes the competition among some of the top global players operating in the market. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.Global Pharmerging Market: SegmentationThe global pharmerging market is divided into: by product, by economic growth levels, by distribution channel and by geography. Product type segment of pharmerging market was divided into Pharmaceuticals (Branded Prescription Drugs, Generic Drugs (Branded Generics, Unbranded Generics), and OTC Drugs) and Healthcare (Medical Devices, and Diagnostic Instruments, Others (IT and record management)). On the basis of Economic Growth Levels the market was divided as - Tier – 1, Tier – 2 and Tier – 3). On the basis of distribution channel the pharmerging market is divided as hospitals, clinics, retail pharmacies, e-commerce, and drug stores.The market for these segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn and market volume in terms of units for the period from 2016 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all segments, considering 2016 as the base year.Geographically, the pharmerging market has been segmented into five regions: North America, Europe, Asia Pacific, Europe, Middle East & Africa (MEA), and Latin America. Each regional market for pharmerging market has been further categorized into major product, applications, material, and end-user segments considered within the scope of the study. Key country (U.S., Canada, Japan, Germany, France, U.K., Australia, Canada, China, Brazil, Mexico, India, etc.) market revenues have also been provided in different regional sections within the report. Market revenue in terms of US$ Mn and volume in terms of units for the period from 2014 to 2025 along with CAGR % from 2016 to 2025 are provided for all the regions and nations considering 2016 as the base year.Companies Mentioned in the Research ReportThe report profiles key manufacturers in the pharmerging market based on various attributes such as company details, SWOT analysis, strategic overview, financials, and business overview. Major players profiled in this report include Abbott Laboratories, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Novartis AG, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., AstraZeneca, GlaxoSmithKline plc., LUPIN, Tata Consultancy Services Limited, Sun Pharmaceutical Industries Ltd., Huadong Medicine Co., Ltd., etc.The global pharmerging Market has been segmented as follows:By Product TypePharmaceuticalsBranded Prescription DrugsGeneric DrugsBranded GenericsUnbranded GenericsOTC DrugsHealthcareMedical DevicesDiagnostic InstrumentsOthers (IT and record management)By IndicationsLifestyle DiseasesCancer and autoimmune diseasesInfectious DiseasesOthersBy Distribution ChannelHospitalsClinicsRetail PharmaciesE-commerceDrug StoresBy RegionEuropeAsia PacificLatin AmericaMiddle East and AfricaDownload the full report: https://www.reportbuyer.com/product/4895309/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.comFor more information: Sarah Smith
Research Advisor at Reportbuyer.com Email: [email protected]
Tel: +44 208 816 85 48 Website: www.reportbuyer.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pharmerging-market-and-healthcare---global-industry-analysis-size-share-growth-trends-and-forecast-2016---2024-300456372.html
SOURCE ReportBuyer
